1/ 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists
Martin H. Bolli, Stefan Abele, Christoph Binkert ect.
J. Med. Chem., 2010, 53 (10), pp 4198–4211
2/ Design, Synthesis, Cytoselective Toxicity, Structure–Activity Relationships, and Pharmacophore of Thiazolidinone Derivatives Targeting Drug-Resistant Lung Cancer Cells
Hongyu Zhou, Shuhong Wu, Shumei Zhai‡, Aifeng Liu, Ying Sun‡, Rongshi Lш, Ying Zhang‡, Sean Ekins#, Peter W. Swaan, Bingliang Fang§, Bin Zhang and Bing Yan
J. Med. Chem., 2008, 51 (5), pp 1242–1251
3/ 2-Thiazolylimino/Heteroarylimino-5-arylidene-4-thiazolidinones as New Agents with SHP-2 Inhibitory Action
A. Geronikaki, P. Eleftheriou, P. Vicini, I. Alam, A. Dixit and A. K. Saxena
J. Med. Chem., 2008, 51 (17), pp 5221–5228
4/ Synthesis and structure-activity relations of a series of antibacterially active 5-(5-nitro-2-furfurylidene)thiazolones, 5-(5-nitro-2-furylpropenylidene)thiazolones, and 6-(5-nitro-2-furyl)-4H-1,3-thiazinones
Eva B. Akerblom
J. Med. Chem., 1974, 17 (6), pp 609–615
5/Thiazolinone analogs of indolmycin with antiviral and antibacterial activity
Michael R. Harnden, Stuart Bailey, Malcolm R. Boyd, Denis R. Taylor, Nicholas D. Wright
J. Med. Chem., 1978, 21 (1), pp 82–87
